Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ekaZCfbwocfbiKfNdSoZ

  ADVERTISEMENT  
February 11, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
 
  • Study: Blood stem cells can eliminate leukemia stem cells
    Maintaining a high level of functioning hematopoietic stem cells -- which produce immune cells, red blood cells and platelets -- may be enough to eliminate leukemia stem cells, according to a study published in the Journal of the Royal Society Interface. Researchers used computer modeling and simulations to test the effect of an HSC-promoting environment on LSCs. Maintaining an environment conducive to healthy cells may be a better approach to eradicating leukemia cells than focusing on cancerous cells directly, researchers said. Oncology Nurse Advisor online (2/8) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Variety is the spice of life.
That's why Quotient sources cells from US, Europe and Asia for its new to the market antibody screens and ID panels, helping you rule out and rule in antibodies. GPOs must like variety too, because Quotient has new contracts with Premier, Amerinet and GSA, saving you money. Find out how the one company focused on manual testing can serve you in 2013 and beyond.

  Science & Health 
 
  • Stem cells could lead to better skin grafts, Canadian researchers say
    University of Calgary researchers are experimenting with stem cells to create skin grafts that perform more like natural skin. Trauma patients, cancer patients and burn survivors would benefit from better split-thickness skin grafts, researchers said. The investigators aim to create skin grafts that promote healing and allow the growth of follicles. CBC.ca (Canada) (2/7) LinkedInFacebookTwitterEmail this Story
 
  • Delivery of clot-busting drug via surgery has benefits, study finds
    Researchers tracked 96 patients with intracerebral hemorrhage and found that those who underwent surgery to receive the clot-busting drug tissue plasminogen activator, or tPA, directly in their brains recovered faster than those who were treated with standard therapy. Patients who received tPA were discharged an average of 38 days earlier, and their blood clots dissolved faster. The study appears in the journal Stroke. HealthDay News (2/7) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Want More CME/CE Credit from AABB?
Now it's even easier to accomplish your training needs and earn CME/CE credits. Convenient and accessible anytime, the AABB Live Learning Center offers quick access to essential Annual Meeting and audioconference content. Most products offer CME/CE tracking and attendance certification. Click here to get started!

  Hot Topics 

Top five news stories selected by AABB SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Emerging Trends 
  • More than 60 ACOs establish national group
    The National Association of ACOs has been established through a collaboration of more than 60 accountable care organizations. The group's mission includes promoting uniform performance and quality measures, as well as educating the public on the importance of accountable care. BeckersHospitalReview.com (2/8) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • Hospitals recognized for use of nursing quality data
    The American Nurses Association honored the six recipients of the National Database of Nursing Quality Indicators Award for Outstanding Nursing Quality, including Robert Wood Johnson University Hospital in New Brunswick, N.J. Of the more than 1,900 hospitals considered for the award, six "demonstrated superior results and sustained improvement in patient outcomes that are tied to the quality of nursing services and nurse work environment factors," the group said. The other recipients are Akron Children's Hospital Mahoning Valley of Boardman, Ohio; Craig Hospital of Englewood, Colo.; Rose Medical Center of Denver; Sharp Mesa Vista Hospital of San Diego; and St. Francis Hospital -- The Heart Center in Roslyn, N.Y. Nurse.com (2/7) LinkedInFacebookTwitterEmail this Story
The Buzz(CORPORATE ANNOUNCEMENTS)

Registration Now Open - April 9, 2013 PACT Workshop
“Developing Cellular Therapies: From Preclinical Safety to Clinical Evaluation”. Hosted by University of Wisconsin, Waisman Biomanufacturing (WB), Madison, WI. No charge for attendance. Click here for more details.


  Government & Regulatory 
  • Senate bill takes aim at 2.3% medical device tax
    A bipartisan bill that would repeal the 2.3% medical device tax has been introduced in the Senate. Industry leaders and lawmakers in favor of the repeal said the tax will threaten job growth and medical innovation. "In order to compete in the global economy, our medical device businesses need a level playing field," said Sen. Amy Klobuchar, D-Minn. Reuters (2/7) LinkedInFacebookTwitterEmail this Story
  • Celgene's multiple myeloma drug Pomalyst wins FDA approval
    The FDA has approved Celgene's Pomalyst, or pomalidomide, as treatment for patients with multiple myeloma who have stopped responding to other therapies. Pomalyst is intended to strengthen the immune system in blocking and eliminating cancer cells. The drug's label will include a warning that it can cause clots and that it should not be used by pregnant women because of the risk for birth defects. HealthDay News (2/8), Reuters (2/8) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Upcoming AABB audioconference to focus on characteristics of an effective team
    Tomorrow's AABB audioconference will review characteristics of an effective team. It also will discuss how teamwork can help organizations achieve specific goals. Learn more. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Donor Collections DirectorBlood Centers of the PacificUS - CA - San Francisco
Medical Technologist CLS - Cord Blood ProgramSan Diego Blood BankUS - CA - San Diego
CLINICAL LABORATORY SCIENTISTBlood Centers of the PacificUS - CA - San Francisco
Click here to view more job listings.

  SmartQuote 
The only man I know who behaves sensibly is my tailor; he takes my measurements anew each time he sees me. ... The rest go on with their old measurements and expect me to fit them."
--George Bernard Shaw,
Irish playwright


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Jennifer Garfinkel

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information